medigraphic.com
Boletín Médico del Hospital Infantil de México

2010, Number 2

<< Back Next >>

Bol Med Hosp Infant Mex 2010; 67 (2)

Lyme disease. Experience in Mexican children

Gordillo PMG, Solórzano SF

Language: Spanish
References: 48
Page: 164-176
PDF size: 233.27 Kb.


ABSTRACT

Lyme disease or Lyme borreliosis is an emerging infectious disease produced by Borrelia burgdorferi sensu lato, which is a bacteria transmitted to the host organism by the bite of Ixodes ticks. In this report we present the general knowledge about the etiological agent, clinical manifestations of the disease and diagnostic laboratory tests. We offer cumulative information about Lyme disease in Mexican children treated at two children’s hospitals in Mexico City during the last 10 years.


REFERENCES

  1. Walther PH, Wilske B, Weber K. Lyme borreliosis: basic science and clinical aspects. Lancet 1994;343:1013-1016.

  2. Steere AC, Malawista SE. Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. Ann Intern Med 1979;91:730-733.

  3. Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A. Longitudinal assessment of clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis 1986;154:295-300.

  4. Guzman L, Neira O. Lyme disease in Chile. J Rheumatol 1993;20:774-775.

  5. Ciceroni L, Bartoloni A, Guglielmetti P. Paradisi F, Barahona HG, Roselli M, et al. Prevalence of antibodies to Borrelia burgdorferi, Borrelia parkeri and Borrelia turicatae in human settlements of the Cordillera Province, Bolivia. J Trop Med Hyg 1994;97:13-17.

  6. Rath PM, Ibershoff B, Mohnhaupt A, Albig J, Eljaschewitsch B, Jürgens D, et al. Seroprevalence of Lyme borreliosis in forestry workers from Brandenburg, Germany. Eur Clin Microb Infect Dis 1996;15:372-377.

  7. Fahrer H, Van der LSM, Sauvain MJ, Gern L, Zhioua E, Aeschliman A. The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J Infect Dis 1991;163:305-310.

  8. CDC. Lyme Disease?United States, 2003-2005. MMWR 2007;56:573-576.

  9. Arroyave CM, Támez GR. Enfermedad de Lyme. Informe de dos casos. Bol Med Hosp Infant Mex 1994;51:117-120.

  10. Gordillo PMG, Solórzano SF, Torres LFJ, Cedillo RR, Tapia CR, Muñóz HO. Serological evidence of Lyme disease in Mexico. Arch Med Res 1999;30:64-68.

  11. Martinez A, Salinas A, Martínez F, Cantu Z, Miller DK. Serosurvey for selected disease agents in white-tailed deer from Mexico. J Wildlife Dis 1999;35:799-803.

  12. Gordillo PG, Estrada G, Solórzano SF, Torres LJ. Confirmación de neuroborreliosis de Lyme por métodos serológicos y moleculares en el Valle de México. Congreso de Neurología, Los Cabos, B.C. Oct 30-Nov 1999; 2. Memorias.

  13. García JI, Gordillo-Pérez G, Corrales L, Torres J, Solórzano-Santos F. Frecuencia de Infección por B. burgdorferi y caracterización clínica de pacientes con parálisis facial en población derechohabiente del IMSS, Zona Sur del Distrito Federal. Congreso Asoc Mex Infectol y Microbiol Clín Guadalajara, Jal. 2001; C33.

  14. Gordillo-Pérez G, Torres J, Solórzano-Santos F, Garduno-Bautista V, Tapia-Conyer R, Muñoz F. Estudio seroepidemiológico de borreliosis de Lyme en la Ciudad de México y el noreste de la República Mexicana. Salud Publica Mex 2003;45:351-355.

  15. Gordillo-Pérez G, Torres J, Solórzano-Santos F. De Martino S., Lipsker D., Velázquez E. et al. Borrelia burgdorferi infection and cutaneous Lyme disease, Mexico. Emerg Infect Dis 2007;13:1556-1558.

  16. Gordillo-Pérez G, Jaulhac B, Torres J, et al. Genotipificación de Borrelia burgdorferi sensu lato de muestras clínicas de pacientes con borreliosis de Lyme adquirida en la República Mexicana por medio de la PCR en tiempo real. XXXI Congreso Anual de la Asociación Mexicana de Infectología y Microbiología Clínica, Aguascalientes, Ags. México 2007:B46.

  17. Steere AC, Malawista SE, Hardin JA, Ruddy S, Arkenase PW, Andiman WA. Erythema chronic migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Int Med 1997;86:685-698.

  18. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985;35:47-53.

  19. Halperin JJ, Little WB, Coyle PK, Dattwyler RJ. Lyme disease: cause of a treatable peripheral neuropathy. Neurology 1987;37:1700-1706.

  20. Feder HM, Zalneraitis EL, Reink L. Lyme disease: acute focal meningoencephalitis in a child. Pediatrics 1988;82:931-934.

  21. Belman AL, Iyer M, Coyle PK, Dattwyler R. Neurologic manifestations in children with North American Lyme disease. Neurology 1993;43:2609-2614.

  22. Shapiro DE, Steere AC, Lesser RL. Lyme disease in children, musculoskeletal and ocular manifestations of Lyme disease. Am J Med 1995;98(suppl 4A):44A-73A.

  23. Frithz A, Lagerholm B. Acrodermatitis chronica atrophicans, erythema migrans and lymphadenosis benigna cutis; spirochetal diseases? Acta Dermatol Venereol 1983;63:432-436.

  24. Strle F, Peterski-Rigle D, Stanek G, Pejovnik-Pustinek A, Rusie E, Cimperman J. Solitary borrelial lymphocytoma: report of 36 cases. Infection 1992;20:201-206.

  25. Gordillo-Pérez MG, Jaulhac B, Velásquez E, Ramón G, Solórzano-Santos F, Torres LJ. Borreliosis de Lyme en niños mexicanos. Congreso de Infectología Pediátrica, Querétaro, Qro. Nov 29-Dec 2, 2007; 46.

  26. CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46 (RR-10):20.

  27. Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev 1986;50:381-400.

  28. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993;167:392-400.

  29. Rusell H, Sampson JS, Schmid GP, Wilkinson HW, Plikaytis B. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis 1984;149:465-470.

  30. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997;10:185-201.

  31. Hauser U, Lehnert G, Lobentanzer R, Wilske B. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1997;35:1433-1444.

  32. Norman GL, Antig JM, Bigaignon G, Hogrefe W. Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B. garinni, and B. afzelii Western blots (immunoblots). J Clin Microbiol 1996;34:1732-1738.

  33. Wang G, Van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 1999;12:633-653.

  34. Postic D, Assous M, Belfaiza J, Baranton G. Genetic diversity of Borrelia of Lyme borreliosis. Wien Klin Wochenschr 1996;108:748-751.

  35. Campbell GL, Mitchell PD, Persing DH. Genetic heterogeneity of Borrelia burgdorferi in the United States. J Infect Dis 1997;175:98-107.

  36. Wilske B, Preac-Mursic V, Göbel UB, Graf B, Jauris S, Soutschek E, et al. An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J Clin Microbiol 1993;31:340-350.

  37. Wilske B, Jauris-Heipke S, Lobentanzer R, Pradel I, Preac-Mursic V, Rössler D, et al. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype. J Clin Microbiol 1995;33:103-109.

  38. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997;10:185-201.

  39. Picken RN. Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. J Clin Microbiol 1992;30:99-114.

  40. Postic D, BelfaizaJ, Isogai E, Saint GI, Grimont PAD, Baranton G. New genomic species in Borrelia burgdorferi sensu lato isolated from Japanese ticks. Res Microbiol 1998;144:467-473.

  41. Schneider BS, Zeidner NS, Burkot TR, Maupin GO, Piesman J. Borrelia isolates in northern Colorado identified as Borrelia bissettii. J Clin Microbiol 2000;38:3103-3105.

  42. Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti JC, Assous M, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992;42:378-383.

  43. Busch U, Hizo TC, Boehmer R. Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed field gel electrophoresis and PCR. J Clin Microbiol 1996;34:1072-1078.

  44. Liveris D, Wormser GP, Nowakowski J. Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 1996;34:1306-1309.

  45. Belfaiza J, Postic D, Bellenger E, Baranton G, Saint G. Genomic fingerprinting of Borrelia burgdorferi sensu lato by pulsed-field gel electrophoresis. J Clin Microbiol 1993;31:2873-2877.

  46. Gautom RK. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli 0157:H7 and other Gram-negative organism in 1 day. J Clin Microbiol 1997;35:2977-2980.

  47. Wang Q, Van Dam AP, Spanjaard L, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato by randomly amplified polymorphic DNA fingerprinting analysis. J Clin Microbiol 1998;36:768-776.

  48. Barbour AG. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev 1988;1:399-414.




2020     |     www.medigraphic.com